Sat, 02-Jul-2022

Roche

FDA Approves Genentech’s Enspryng for Neuromyeliti...

Genentech, a member of the Roche Group, announced that the U.S. Food and Drug Administration (FDA) has approved Enspryng (satralizumab-mwge) as the subcutaneous treatment for adults living with anti-aquaporin... August 17, 2020 6:17 am By Neha Mule

Roche Mixes Actemra with Gilead’s Remdesivir in CO...

Roche plans to test if mixing its anti-inflammation drug Actemra with Gilead Sciences Inc’s anti-viral treatment remdesivir works better against severe COVID-19 pneumonia than remdesivir alone, the Swiss dru... May 28, 2020 10:58 am By Neha Mule

Roche in Talks with UK Government to Roll Out Corona...

Swiss drugmaker Roche Holding AG said on Wednesday it was in talks with the UK government to roll out its coronavirus antibody test kits in the country after Public Health England (PHE) found them reliable. ... May 14, 2020 8:22 am By Neha Mule

Case Study: Roche Diagnostics Enhances Warehouse Pra...

For every supply chain professional, implantation of right tools has become essential to manage warehouse operations and distribution processes these days. Roche Diagnostics Operations (RDO) of Roche compared ... May 1, 2020 7:21 am By Neha Mule

Roche Clears UK Hurdle in $4.3 Billion Spark Deal

Swiss drugmaker Roche won clearance from Britain’s Competition and Markets Authority (CMA) on Monday for its planned $4.3 billion takeover of gene therapy company Spark Therapeutics, while a similar U.S. rev... December 16, 2019 8:30 am By Neha Mule

FDA Approves Roche’s Tecentriq Plus Chemotherapy f...

Roche announced that the US Food and Drug Administration (FDA) approved Tecentriq (atezolizumab) in combination with chemotherapy (Abraxane [paclitaxel protein-bound; nab-paclitaxel] and carboplatin) for the i... December 4, 2019 9:21 am By Neha Mule

Related News